U.S. Markets close in 32 mins.

Celgene Corporation (CELG)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
137.63+1.32 (+0.97%)
As of 3:28PM EDT. Market open.
People also watch
GILDBIIBREGNAMGNALXN
Full screen
Previous Close136.31
Open136.23
Bid137.69 x 500
Ask137.71 x 200
Day's Range135.72 - 138.17
52 Week Range96.93 - 138.17
Volume2,914,630
Avg. Volume3,952,476
Market Cap107.46B
Beta1.47
PE Ratio (TTM)51.68
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Barrons.com23 minutes ago

    Nothing Can Keep Celgene Down

    When it comes to Celgene (CELG), what goes might must keep going up. Shares of Celgene started rallying on June 1, and after taking a break through the first couple of weeks of July, its shares are on the move again. In fact Celgene is trading a new 52-week high today.

  • Barrons.com2 hours ago

    Will Gilead Beat 2Q Earnings? Perhaps…But Does It Matter?

    Is Gilead Sciences (GILD) poised for a beat next week? Guggenheim analyst Tony Butler sees Gilead earning $2.15 a share, a penny above the consensus forecast compiled by sell-side analyst, with operating revenue of $6.54 billion beating the $6.31 billion expected by the Street. Butler’s estimates for the full 2017 calendar year are also above consensus, with per-share earnings of $8.28 on operating revenue of $25.4 billion.

  • Reuters2 hours ago

    US STOCKS-Wall Street pares losses but GE-led industrials weigh

    U.S. stock indexes pared losses, helped by a rise in Visa in early afternoon trading on Friday, but weak earnings from industrial heavyweight General Electric weighed. Shares of GE fell as much as 5.4 percent to their lowest level since Oct 2015, as the company reported a nearly 60 percent slump in profit and its 2017 profit forecast came in at the low end.